anti aβ rabbit polyclonal primary antibody Search Results


90
Bioworld Antibodies rabbit anti-rat amyloid beta (aβ) primary antibody
Effect of GCs on p-tau and <t>Aβ</t> immunoreactivity in the hippocampus of a rat model of vascular dementia. (A–F) Representative immunohistochemical images for p-tau and Aβ staining. Cells immunopositive for p-tau (A–C) and Aβ (D–F) in control (A, D), vascular dementia model (B, E), and GC-treated (C, F) rats. Black arrows indicate immunopositive cells, with orange-brown staining in the cytoplasm indicating p-tau and Aβ imunoreactivity. (G) Average gray values of p-tau and Aβ in control rats, vascular dementia rats and CG-treated rats. p-tau and Aβ immunoreactivity was greater in the vascular dementia group than in the control group. This upregulation was significantly decreased after treatment with GC. Data are expressed as the mean ± SD. * P < 0.05, # P < 0.05 (two-way analysis of variance). Experiments were conducted in triplicate. GC: Glycosides of Cistanche ; p-tau: phosphorylated tau; Aβ: amyloid <t>beta;</t> VD: vascular dementia.
Rabbit Anti Rat Amyloid Beta (Aβ) Primary Antibody, supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-rat amyloid beta (aβ) primary antibody/product/Bioworld Antibodies
Average 90 stars, based on 1 article reviews
rabbit anti-rat amyloid beta (aβ) primary antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Rockland Immunochemicals primary antibodies polyclonal rabbit anti-mouse aβ
Effect of GCs on p-tau and <t>Aβ</t> immunoreactivity in the hippocampus of a rat model of vascular dementia. (A–F) Representative immunohistochemical images for p-tau and Aβ staining. Cells immunopositive for p-tau (A–C) and Aβ (D–F) in control (A, D), vascular dementia model (B, E), and GC-treated (C, F) rats. Black arrows indicate immunopositive cells, with orange-brown staining in the cytoplasm indicating p-tau and Aβ imunoreactivity. (G) Average gray values of p-tau and Aβ in control rats, vascular dementia rats and CG-treated rats. p-tau and Aβ immunoreactivity was greater in the vascular dementia group than in the control group. This upregulation was significantly decreased after treatment with GC. Data are expressed as the mean ± SD. * P < 0.05, # P < 0.05 (two-way analysis of variance). Experiments were conducted in triplicate. GC: Glycosides of Cistanche ; p-tau: phosphorylated tau; Aβ: amyloid <t>beta;</t> VD: vascular dementia.
Primary Antibodies Polyclonal Rabbit Anti Mouse Aβ, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies polyclonal rabbit anti-mouse aβ/product/Rockland Immunochemicals
Average 90 stars, based on 1 article reviews
primary antibodies polyclonal rabbit anti-mouse aβ - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GeneTex anti-beta-amyloid gtx82974
Effect of GCs on p-tau and <t>Aβ</t> immunoreactivity in the hippocampus of a rat model of vascular dementia. (A–F) Representative immunohistochemical images for p-tau and Aβ staining. Cells immunopositive for p-tau (A–C) and Aβ (D–F) in control (A, D), vascular dementia model (B, E), and GC-treated (C, F) rats. Black arrows indicate immunopositive cells, with orange-brown staining in the cytoplasm indicating p-tau and Aβ imunoreactivity. (G) Average gray values of p-tau and Aβ in control rats, vascular dementia rats and CG-treated rats. p-tau and Aβ immunoreactivity was greater in the vascular dementia group than in the control group. This upregulation was significantly decreased after treatment with GC. Data are expressed as the mean ± SD. * P < 0.05, # P < 0.05 (two-way analysis of variance). Experiments were conducted in triplicate. GC: Glycosides of Cistanche ; p-tau: phosphorylated tau; Aβ: amyloid <t>beta;</t> VD: vascular dementia.
Anti Beta Amyloid Gtx82974, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-beta-amyloid gtx82974/product/GeneTex
Average 90 stars, based on 1 article reviews
anti-beta-amyloid gtx82974 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Amyjet Scientific Inc rabbit anti-aβ primary antibody abp57498
Effect of GCs on p-tau and <t>Aβ</t> immunoreactivity in the hippocampus of a rat model of vascular dementia. (A–F) Representative immunohistochemical images for p-tau and Aβ staining. Cells immunopositive for p-tau (A–C) and Aβ (D–F) in control (A, D), vascular dementia model (B, E), and GC-treated (C, F) rats. Black arrows indicate immunopositive cells, with orange-brown staining in the cytoplasm indicating p-tau and Aβ imunoreactivity. (G) Average gray values of p-tau and Aβ in control rats, vascular dementia rats and CG-treated rats. p-tau and Aβ immunoreactivity was greater in the vascular dementia group than in the control group. This upregulation was significantly decreased after treatment with GC. Data are expressed as the mean ± SD. * P < 0.05, # P < 0.05 (two-way analysis of variance). Experiments were conducted in triplicate. GC: Glycosides of Cistanche ; p-tau: phosphorylated tau; Aβ: amyloid <t>beta;</t> VD: vascular dementia.
Rabbit Anti Aβ Primary Antibody Abp57498, supplied by Amyjet Scientific Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-aβ primary antibody abp57498/product/Amyjet Scientific Inc
Average 90 stars, based on 1 article reviews
rabbit anti-aβ primary antibody abp57498 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Senetek plc polyclonal rabbit anti-aβ antibody
Effect of GCs on p-tau and <t>Aβ</t> immunoreactivity in the hippocampus of a rat model of vascular dementia. (A–F) Representative immunohistochemical images for p-tau and Aβ staining. Cells immunopositive for p-tau (A–C) and Aβ (D–F) in control (A, D), vascular dementia model (B, E), and GC-treated (C, F) rats. Black arrows indicate immunopositive cells, with orange-brown staining in the cytoplasm indicating p-tau and Aβ imunoreactivity. (G) Average gray values of p-tau and Aβ in control rats, vascular dementia rats and CG-treated rats. p-tau and Aβ immunoreactivity was greater in the vascular dementia group than in the control group. This upregulation was significantly decreased after treatment with GC. Data are expressed as the mean ± SD. * P < 0.05, # P < 0.05 (two-way analysis of variance). Experiments were conducted in triplicate. GC: Glycosides of Cistanche ; p-tau: phosphorylated tau; Aβ: amyloid <t>beta;</t> VD: vascular dementia.
Polyclonal Rabbit Anti Aβ Antibody, supplied by Senetek plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti-aβ antibody/product/Senetek plc
Average 90 stars, based on 1 article reviews
polyclonal rabbit anti-aβ antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Effect of GCs on p-tau and Aβ immunoreactivity in the hippocampus of a rat model of vascular dementia. (A–F) Representative immunohistochemical images for p-tau and Aβ staining. Cells immunopositive for p-tau (A–C) and Aβ (D–F) in control (A, D), vascular dementia model (B, E), and GC-treated (C, F) rats. Black arrows indicate immunopositive cells, with orange-brown staining in the cytoplasm indicating p-tau and Aβ imunoreactivity. (G) Average gray values of p-tau and Aβ in control rats, vascular dementia rats and CG-treated rats. p-tau and Aβ immunoreactivity was greater in the vascular dementia group than in the control group. This upregulation was significantly decreased after treatment with GC. Data are expressed as the mean ± SD. * P < 0.05, # P < 0.05 (two-way analysis of variance). Experiments were conducted in triplicate. GC: Glycosides of Cistanche ; p-tau: phosphorylated tau; Aβ: amyloid beta; VD: vascular dementia.

Journal: Neural Regeneration Research

Article Title: Effect of glycosides of Cistanche on the expression of mitochondrial precursor protein and keratin type II cytoskeletal 6A in a rat model of vascular dementia

doi: 10.4103/1673-5374.211196

Figure Lengend Snippet: Effect of GCs on p-tau and Aβ immunoreactivity in the hippocampus of a rat model of vascular dementia. (A–F) Representative immunohistochemical images for p-tau and Aβ staining. Cells immunopositive for p-tau (A–C) and Aβ (D–F) in control (A, D), vascular dementia model (B, E), and GC-treated (C, F) rats. Black arrows indicate immunopositive cells, with orange-brown staining in the cytoplasm indicating p-tau and Aβ imunoreactivity. (G) Average gray values of p-tau and Aβ in control rats, vascular dementia rats and CG-treated rats. p-tau and Aβ immunoreactivity was greater in the vascular dementia group than in the control group. This upregulation was significantly decreased after treatment with GC. Data are expressed as the mean ± SD. * P < 0.05, # P < 0.05 (two-way analysis of variance). Experiments were conducted in triplicate. GC: Glycosides of Cistanche ; p-tau: phosphorylated tau; Aβ: amyloid beta; VD: vascular dementia.

Article Snippet: Sections were then incubated in rabbit anti-rat phosphorylated p-tau primary antibody (1:1,000 in PBS; Bioworld Technology, Inc., TX, USA) and rabbit anti-rat amyloid beta (Aβ) primary antibody (1:1,000; Bioworld Technology, Inc.) in a wet box at 37°C for 2–3 hours, before incubation in the secondary antibody (goat anti-mouse IgG; Bioworld Technology, Inc.) for 15 minutes at room temperature.

Techniques: Immunohistochemical staining, Staining